NASDAQ NMS - GLOBAL MARKET · RXRX
-2.74% · -$0.1000 · Vol Not reported
Live · updated 13:56:02 ET
Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals Inc

Biotechnology
$3.73
Card
Relationship Map

Follow $RXRX

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $RXRX by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measuredMethodology
RXRX
Recursion Pharmaceuticals Inc
Tue Oct 13 · last completed session · daily score · 20h old
Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

67/ 100
Veridion Score
Upper range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →or $250/yr
Cancel anytime · or Reserve · $79/moor $790/yr
Confidence: HIGH · 6 of 6 factors measured · Tue Oct 13 · last completed session · daily score · 20h old
Share on X →
AI Analysis
Sovereign

Why is RXRX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and available price action.
About Recursion Pharmaceuticals Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2021
Employees
600
Country
US

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$3.73
Day high
$3.92
Day low
$3.66
Previous close
$3.83
52W high
$6.79
-45.07% from high
52W low
$2.84
23% of range
Market cap
$2.1B
EPS
$-1.0382
Beta
2.98
Shares out
536.3M
Avg volume
25.2M
VWAP
$3.83
Last session
Price history computed in-house
1W
-12.65%
1M
+9.38%
3M
+23.51%
1Y
-36.67%
YTD
-8.80%
SMA 50 $3.59 · above
SMA 200 $3.57 · above
52W position 23%

RXRX overview

Veridion Score
67
Registered · 2026-10-13
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around RXRX.Congress trackerSearch the public STOCK Act disclosure ledger.Thematic map · TechBio & AI Drug DiscoveryMethodologyReview score inputs, coverage rules, and limitations.
Public disclosures

Congress activity in RXRX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

RXRX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for RXRX in this window.
Lobbying spend

RXRX lobbying filings, year to date.

Registered lobbying filings matched to Recursion Pharmaceuticals Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for RXRX in this window.
Analyst ratings
Sovereign unlock shows available analyst consensus for RXRX.
Veridion by email

Disclosure findings, methodology notes, and product updates when we have them. No fixed schedule yet. No advertising list resale.